BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/23/2017 10:56:00 AM | Browse: 1523 | Download: 2666
Publication Name World Journal of Rheumatology
Manuscript ID 31724
Country Lebanon
ISSN 2220-3214 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Rheumatology
Manuscript Type Observational Study
Article Title Physicians’ knowledge and attitude regarding bisphosphonates-related adverse events: An observational study
Manuscript Source Unsolicited Manuscript
All Author List Lana El Osta, Nada El Osta, Reine Tannous, Antoine Aoun, Marwan Ghosn and Hazem El Osta
Funding Agency and Grant Number
Corresponding Author Lana El Osta, MD, Department of Public Health, School of Medicine, Saint-Joseph University, PO Box 11-5076, Riad El Solh, Beirut 1107 2180, Lebanon. lanaosta@hotmail.com
Key Words Knowledge; Bisphosphonates; Malignant bone diseases; Osteoporosis; Drug complications
Core Tip Bisphosphonates (BPs) have been proven to be effective, tolerated and relatively safe to a large number of patients. However, they were associated with reports of multiple adverse events. Given the widespread use of these medications, detailed knowledge on occurrence of even rare side effects is imperative. In this study, we assess the knowledge and approach of our physicians regarding BPs-related complications. Eventually, this evaluation will facilitate the elaboration of appropriate training programs to increase their awareness and improve their practice. It will incite pharmaceutical companies to reconsider the instructions they provide to physicians about the complications of treatments they promote.
Publish Date 2017-03-23 10:56
Citation El Osta L, El Osta N, Tannous R, Aoun A, Ghosn M, El Osta H. Physicians’ knowledge and attitude regarding bisphosphonates-related adverse events: An observational study. World J Rheumatol 2017; 7(1): 1-7
URL http://www.wjgnet.com/2220-3214/full/v7/i1/1.htm
DOI http://dx.doi.org/10.5499/wjr.v7.i1.1
Full Article (PDF) WJR-7-1.pdf
Full Article (Word) WJR-7-1.doc